Tourmaline Bio Inc
NASDAQ:TRML

Watchlist Manager
Tourmaline Bio Inc Logo
Tourmaline Bio Inc
NASDAQ:TRML
Watchlist
Price: 47.98 USD Market Closed
Market Cap: 1.2B USD

During the last 3 months Tourmaline Bio Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 1% over this period (open performance analysis).

The last transaction was made on Aug 21, 2024 by Kulkarni Sandeep Chidambar , who bought 26.4k USD worth of TRML shares.

Last Transactions:
Kulkarni Sandeep Chidambar
$+26.4k
Kulkarni Sandeep Chidambar
$+72k
Mcdade Mark
$+3.3m
Kulkarni Sandeep Chidambar
$+68k
Thiara Parvinder
$+17.3k
View All Transactions

During the last 3 months Tourmaline Bio Inc insiders have not bought any shares, and have not sold any shares. The stock price has increased by 1% over this period (open performance analysis).

The last transaction was made on Aug 21, 2024 by Kulkarni Sandeep Chidambar , who bought 26.4k USD worth of TRML shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

Tourmaline Bio Inc
Insider Trading Chart

Tourmaline Bio Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Tourmaline Bio Inc
Last Insider Transactions

Global
Insiders Monitor

Tourmaline Bio Inc
Glance View

Market Cap
1.2B USD
Industry
Biotechnology

Tourmaline Bio Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Louisville, Kentucky and currently employs 129 full-time employees. The company went IPO on 2021-05-07. Tourmaline Bio, Inc., formerly Talaris Therapeutics, Inc., is a late-stage clinical biotechnology company. The firm is engaged in developing transformative medicines that improve the lives of patients with life-altering immune diseases. The Company’s lead program, TOUR006, is an anti-interleukin-6 (IL-6) antibody that exhibits differentiated properties, including high binding affinity to IL-6 and a naturally long half-life. TOUR006 selectively binds to IL-6, a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory diseases. The firm focuses on developing TOUR006 in thyroid eye disease (TED) and atherosclerotic cardiovascular disease (ASCVD) as its first two indications, with additional indications under consideration. TED is a debilitating autoimmune disorder. ASCVD is a group of disorders caused by plaque buildup and rupture in the artery walls and includes myocardial infarctions (heart attacks) and strokes.

TRML Intrinsic Value
Not Available

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top